Zhao Luodan, Ren Yuexin, Tang Haikuo, Wang Wei, He Qianting, Sun Jingjing, Zhou Xiaofeng, Wang Anxun
Department of Oral and Maxillofacial Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Oncotarget. 2015 Dec 29;6(42):44538-50. doi: 10.18632/oncotarget.6253.
Chemoresistance is often associated with other clinical characteristics such as enhanced migratory/invasive potential. However, the correlation and underlying molecular mechanisms remain unclear. The aim of this study was to elucidate the function of the miR-222-ABCG2 pathway in the correlation between cisplatin (DDP) resistance and enhanced cell migration/invasion in tongue squamous cell carcinoma (TSCC). Using TSCC cell lines and primary cultures from TSCC cases, we first confirmed the correlation among DDP resistance (measured by IC50 values and ABCG2/ERCC1 expression), migratory/invasive potential (assessed by migration/invasion assays) and miR-222 expression. In TSCC cells, siRNA-mediated ABCG2 knockdown led to enhanced DDP responsiveness and reduced migratory/invasive potential, whereas ABCG2 overexpression induced DDP resistance and enhanced cell migration/invasion. Luciferase assays revealed that ABCG2 is a direct target of miR-222. In addition to reducing cell migration/invasion, functional analyses in TSCC cells indicated that miR-222 can reduce expression of the ABCG2 gene and enhance DDP responsiveness. However, co-transfection with ABCG2 cDNA restored both DDP resistance and migration/invasion. Moreover, miR-222 mimics and ABCG2 siRNA inhibited tumor growth and lung metastasis in vivo. Thus, our results verified that DDP resistance is correlated with enhanced migratory/invasive potential in TSCC. ABCG2 is a direct target of miR-222,and deregulation of the miR-222-ABCG2 regulatory module in TSCC contributes to both DDP resistance and enhanced migratory/invasive potential.
化疗耐药通常与其他临床特征相关,如迁移/侵袭潜能增强。然而,其相关性及潜在分子机制仍不清楚。本研究的目的是阐明miR-222-ABCG2通路在舌鳞状细胞癌(TSCC)顺铂(DDP)耐药与细胞迁移/侵袭增强之间的相关性中的作用。利用TSCC细胞系和TSCC病例的原代培养物,我们首先证实了DDP耐药(通过IC50值和ABCG2/ERCC1表达来衡量)、迁移/侵袭潜能(通过迁移/侵袭实验评估)与miR-222表达之间的相关性。在TSCC细胞中,siRNA介导的ABCG2基因敲低导致DDP反应性增强和迁移/侵袭潜能降低,而ABCG2过表达则诱导DDP耐药并增强细胞迁移/侵袭。荧光素酶实验表明ABCG2是miR-222的直接靶点。除了降低细胞迁移/侵袭外,TSCC细胞中的功能分析表明,miR-222可降低ABCG2基因的表达并增强DDP反应性。然而,与ABCG2 cDNA共转染可恢复DDP耐药性以及迁移/侵袭能力。此外,miR-222模拟物和ABCG2 siRNA在体内可抑制肿瘤生长和肺转移。因此,我们的结果证实了TSCC中的DDP耐药与迁移/侵袭潜能增强相关。ABCG2是miR-222的直接靶点,TSCC中miR-222-ABCG2调控模块的失调导致了DDP耐药和迁移/侵袭潜能增强。